Last reviewed · How we verify
Standard analgesia use [Fentanyl]
Standard analgesia use [Fentanyl] is a Small molecule drug developed by Johns Hopkins University. It is currently in Phase 1 development.
At a glance
| Generic name | Standard analgesia use [Fentanyl] |
|---|---|
| Sponsor | Johns Hopkins University |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Standard analgesia use [Fentanyl] CI brief — competitive landscape report
- Standard analgesia use [Fentanyl] updates RSS · CI watch RSS
- Johns Hopkins University portfolio CI
Frequently asked questions about Standard analgesia use [Fentanyl]
What is Standard analgesia use [Fentanyl]?
Standard analgesia use [Fentanyl] is a Small molecule drug developed by Johns Hopkins University.
Who makes Standard analgesia use [Fentanyl]?
Standard analgesia use [Fentanyl] is developed by Johns Hopkins University (see full Johns Hopkins University pipeline at /company/johns-hopkins-university).
What development phase is Standard analgesia use [Fentanyl] in?
Standard analgesia use [Fentanyl] is in Phase 1.